A Study of Genital Cytology and Pathology in Patients with Confirmed HPV Associated Oropharyngeal Carcinoma


About this study

The purpose of this study is to determine the incidence of concomitant HPV associated genital lesions in female patients with confirmed HPV associated oropharyngeal cancers, to determine the risk of requiring additional procedures or treatments secondary to these diagnoses, and to determine the HPV subtypes and other risk factors associated with genital dysplasia among those with documented HPV status.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • All female patients seen in consultation at Mayo clinic Rochester through 2018 with the diagnosis of oropharyngeal carcinoma.

Exclusion Criteria:

  • Non-HPV associated tumors
  • Male patients.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kathryn Van Abel, M.D.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer